INS and diabetes mellitus: While insulin has been identified as a critical autoantigen, the list of diabetes-associated autoantigens continues to grow and now includes post-translationally modified neoepitopes and hybrid insulin peptides, generated at the site of autoimmune attack in the islet [90].